Brief: ChromoGenics Q3 Operating Loss Narrows To SEK 6.3 Mln
Nov 12 (Reuters) - ChromoGenics AB CHRO.ST :
* OPERATING LOSS FOR Q3 2021 AMOUNTED TO SEK -6.3 (-14.4)
MILLION
* ORDER VOLUME GOING INTO Q4 2021 AMOUNTS TO SEK 24.8 (9.7)
MILLION.
* NET SALES FOR Q3 2021 AMOUNTED TO SEK 7.7 (3.5) MILLION,
AND
EARNINGS AMOUNTED TO SEK -7.3 (-15.1) MILLION
Source text for Eikon: ID:nWkr3089y9
Further company coverage: CHRO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on ChromoGenics AB
See all newsBrief: Chromogenics Says Conditional Loan Of SEK 47.6 Mln Is Converted To Grant
Brief: Färna Invest Makes SEK 10/Shr Offer For Chromogenics
Brief: Chromogenics Q1 Pre-Tax Loss Widens To SEK 13.6 Mln
Brief: Chromogenics Gets First Order For North America
Brief: Chromogenics Initiates Cost Reduction Program